Abdominal aortic aneurysm (AAA), in which the wall of the body’s largest artery thins to the point of rupture, is more and more frequently being treated with less invasive rather than open surgical means. Endovascular aortic repair for the abdominal aorta, or EVAR, now amounts to a $1.5 to $1.6 billion-and-growing market. Active efforts are underway to improve upon current technology so as to access a larger patient pool.
Vying with the traditional Big Three – Medtronic PLC, Cook Medical Inc./Cook Group Inc. and WL Gore & Associates Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?